Erratum: High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease (Heart (2009) 95, (2023-2028) doi:10.1136/hrt.2009.170241);High serum levels of procollagen type III N-terminal amino peptide in patients with congenital heart disease

Heart

Volumn 95, Issue 24, 2009, Pages 2023-2028

  Sugimoto, M ^a,b   Masutani, S ^a   Seki, M ^a   Kajino, H ^b   Fujieda, K ^b   Senzaki, H ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; COLLAGEN TYPE 3; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; OXYGEN; PETHIDINE; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; THIAMYLAL;

AORTA COARCTATION; AORTA STENOSIS; ARTERIAL OXYGEN SATURATION; ARTICLE; CHILD; CONTINUOUS INFUSION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYANOSIS; DISEASE SEVERITY; FALLOT TETRALOGY; FIBROGENESIS; HEART ATRIUM SEPTUM DEFECT; HEART CATHETERIZATION; HEART HEMODYNAMICS; HEART MUSCLE FIBROSIS; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE VOLUME; HUMAN; HYPOXEMIA; IMMUNORADIOMETRIC ASSAY; INFANT; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PULMONARY VALVE STENOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SCHOOL CHILD;

EID: 71749103511     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrtjnl-2012-114306-170241     Document Type: Erratum

References (41)

1. McLenachan JM, Dargie HJ. Ventricular arrhythmias in hypertensive left ventricular hypertrophy. Relationship to coronary artery disease, left ventricular dysfunction, and myocardial fibrosis. Am J Hypertens 1990;3:735-740 (Pubitemid 20345997)
2. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999;79:215-262
3. Klappacher G, Franzen P, Haab D, et al. Measuring extracellular matrix turnover in the serum of patients with idiopathic or ischemic dilated cardiomyopathy and impact on diagnosis and prognosis. Am J Cardiol 1995;75:913-918
4. Diez J, Laviades C. Monitoring fibrillar collagen turnover in hypertensive heart disease. Cardiovasc Res 1997;35:202-205 (Pubitemid 27372031)
5. Jensen LT, Horslev-Petersen K, Toft P, et al. Serum aminoterminal type III procollagen peptide reflects repair after acute myocardial infarction. Circulation 1990;81:52-57 (Pubitemid 20031766)
6. Diez J, Laviades C, Mayor G, et al. Increased serum concentrations of procollagen peptides in essential hypertension: relation to cardiac alterations. Circulation 1995;91:1450-1456
7. Tsutamoto T, Wada A, Maeda K, et al. Spironolactone inhibits the transcardiac extraction of aldosterone in patients with congestive heart failure. J Am Coll Cardiol 2000;36:838-844 (Pubitemid 30681607)
8. Laviades C, Mayor G, Diez J. Treatment with lisinopril normalizes serum concentrations of procollagen type III amino-terminal peptide in patients with essential hypertension. Am J Hypertens 1994;7:52-58 (Pubitemid 24033219)
9. Hayashi M, Tsutamoto T, Wada A, et al. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction. Circulation 2003;107:2559-2565 (Pubitemid 36628936)
10. Umar S, Bax JJ, Klok M, et al. Myocardial collagen metabolism in failing hearts before and during cardiac resynchronization therapy. Eur J Heart Fail 2008;10:878-883
11. Host NB, Jensen LT, Bendixen PM, et al. The aminoterminal propeptide of type III procollagen provides new information on prognosis after acute myocardial infarction. Am J Cardiol 1995;76:869-873
12. Poulsen SH, Host NB, Jensen SE, et al. Relationship between serum amino-terminal propeptide of type III procollagen and changes of left ventricular function after acute myocardial infarction. Circulation 2000;101:1527-1532
13. Senzaki H, Chen CH, Masutani S, et al. Assessment of cardiovascular dynamics by pressure-area relations in pediatric patients with congenital heart disease. J Thorac Cardiovasc Surg 2001;122:535-547 (Pubitemid 32843956)
14. Ratnasamy C, Kinnamon DD, Lipshultz SE, et al. Associations between neurohormonal and inflammatory activation and heart failure in children. Am Heart J 2008;155:527-533
15. Doering CW, Jalil JE, Janicki JS, et al. Collagen network remodelling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy. Cardiovasc Res 1988;22:686-695
16. Michel JB, Salzmann JL, Ossondo Nlom M, et al. Morphometric analysis of collagen network and plasma perfused capillary bed in the myocardium of rats during evolution of cardiac hypertrophy. Basic Res Cardiol 1986;81:142-154 (Pubitemid 16111890)
17. Falanga V, Zhou L, Yufit T. Low oxygen tension stimulates collagen synthesis and COL1A1 transcription through the action of TGF-beta1. J Cell Physiol 2002;191:42-50. (Pubitemid 34195216)
18. Chapmam C, Weber KT, Eghbali M. Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium. Cir Res 1990;67:787-794 (Pubitemid 20315010)
19. Holubarsch C. Contracture type and fibrosis type of decreased myocardial distensibility. Different changes in elasticity of myocardium in hypoxia and hypertrophy. Basic Res Cardiol 1980;75:244-252
20. Trivedi P, Cheeseman P, Portmann B, et al. Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children and adults with chronic active hepatitis. Eur J Clin Invest 1985;15:69-74. (Pubitemid 15109228)
21. Risteli J, Niemi S, Trivedi P, et al. Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. Clin Chem 1988;34:715-718 (Pubitemid 18129776)
22. Babu-Narayan SV, Kilner PJ, Li W, et al. Ventricular fibrosis suggested by cardiovascular magnetic resonance in adults with repaired tetralogy of Fallot and its relationship to adverse markers of clinical outcome. Circulation 2006;113:405-413 (Pubitemid 43803202)
23. Hartke LP, Gilkeson RC, O'Riordan MA, et al. Evaluation of right ventricular fibrosis in adult congenital heart disease using gadolinium-enhanced magnetic resonance imaging: initial experience in patients with right ventricular loading conditions. Cong Heart Dis 2006;1:192-201.
24. Ho SY, Jackson M, Kilpatrick L, et al. Fibrous matrix of ventricular myocardium in tricuspid atresia compared with normal heart. A quantitative analysis. Circulation 1996;94:1642-1646
25. Padalino MA, Castellani C, Toffoli S, et al. Pathological changes and myocardial remodelling related to the mode of shunting following surgical palliation for hypoplastic left heart syndrome. Cardiol Young 2008;18:415-422 (Pubitemid 352044189)
26. Weber KT, Brilla CG, Janicki JS. Myocardial fibrosis: functional significance and regulatory factors. Cardiovasc Res 1993;27:341-348
27. MacKenna D, Summerour SR, Villarreal FJ. Role of mechanical factors in modulating cardiac fibroblast function and extracellular matrix synthesis. Cardiovasc Res 2000;46:257-263 (Pubitemid 30204597)
28. Cicoira M, Rossi A, Bonapace S, et al. Independent and additional prognostic value of aminoterminal propeptide of type III procollagen circulating levels in patients with chronic heart failure. J Card Fail 2004;10:403-411 (Pubitemid 41080221)
29. Sun Y, Ratajska A, Zhou G, et al. Angiotensin-converting enzyme and myocardial fibrosis in the rat receiving angiotensin II or aldosterone. J Lab Clin Med 1993;122:395-403. (Pubitemid 23346774)
30. Villarreal FJ, Kim NN, Ungab GD, et al. Identification of functional angiotensin II receptors on rat cardiac fibroblasts. Circulation 1993;88:2849-2861 (Pubitemid 23360212)
31. Brilla CG, Zhou G, Matsubara L, et al. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone. J Mol Cell Cardiol 1994;26:809-820 (Pubitemid 24223231)
32. Zannad F, Alla F, Dousset B, et al. Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES). Rales Investigators. Circulation 2000;102:2700-2706 (Pubitemid 30949246)
33. Timonen P, Magga J, Risteli J, et al. Cytokines, interstitial collagen and ventricular remodelling in dilated cardiomyopathy. Int J Cardiol 2008;124:293-300. (Pubitemid 351305377)
34. Rossi A, Cicoira M, Golia G, et al. Amino-terminal propeptide of type III procollagen is associated with restrictive mitral filling pattern in patients with dilated cardiomyopathy: a possible link between diastolic dysfunction and prognosis. Heart 2004;90:650-654 (Pubitemid 38668539)
35. Bauersachs J, Fraccarollo D. More NO-no more ROS: combined selective mineralocorticoid receptor blockade and angiotensin-converting enzyme inhibition for vascular protection. Hypertension 2008;51:624-625 (Pubitemid 351301511)
36. Moens AL, Takimoto E, Tocchetti CG, et al. Reversal of cardiac hypertrophy and fibrosis from pressure overload by tetrahydrobiopterin: efficacy of recoupling nitric oxide synthase as a therapeutic strategy. Circulation 2008;117:2626-2636
37. Senzaki H, Paolocci N, Gluzband YA, et al. Beta-blockade prevents sustained metalloproteinase activation and diastolic stiffening induced by angiotensin II combined with evolving cardiac dysfunction. Cir Res 2000;86:807-815 (Pubitemid 30217831)
38. Paolocci N, Tavazzi B, Biondi R, et al. Metalloproteinase inhibitor counters high-energy phosphate depletion and AMP deaminase activity enhancing ventricular diastolic compliance in subacute heart failure. J Pharmacol Exp Ther 2006;317:506-513
39. Martos R, Baugh J, Ledwidge M, et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007;115:888-895 (Pubitemid 46294729)
40. Schaper J, Froede R, Hein S, et al. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy. Circulation 1991;83:504-514
41. Senzaki H. The pathophysiology of coronary artery aneurysms in Kawasaki disease: role of matrix metalloproteinases. Arch Dis Child 2006;91:847-851 (Pubitemid 44521172)